- Home
- VMD vs CYRX Comparison
VMD vs CYRX Comparison
Compare VMD & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMD
- CYRX
- Stock Information
- Founded
- VMD 2006
- CYRX 1999
- Country
- VMD United States
- CYRX United States
- Employees
- VMD N/A
- CYRX N/A
- Industry
- VMD
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- VMD
- CYRX Health Care
- Exchange
- VMD Nasdaq
- CYRX Nasdaq
- Market Cap
- VMD 279.4M
- CYRX 277.5M
- IPO Year
- VMD N/A
- CYRX N/A
- Fundamental
- Price
- VMD $6.65
- CYRX $6.01
- Analyst Decision
- VMD
- CYRX Strong Buy
- Analyst Count
- VMD 0
- CYRX 8
- Target Price
- VMD N/A
- CYRX $10.75
- AVG Volume (30 Days)
- VMD 190.9K
- CYRX 449.3K
- Earning Date
- VMD 05-07-2025
- CYRX 05-07-2025
- Dividend Yield
- VMD N/A
- CYRX N/A
- EPS Growth
- VMD 19.95
- CYRX N/A
- EPS
- VMD 0.30
- CYRX N/A
- Revenue
- VMD $232,793,000.00
- CYRX $232,134,000.00
- Revenue This Year
- VMD $17.35
- CYRX N/A
- Revenue Next Year
- VMD $12.87
- CYRX $9.41
- P/E Ratio
- VMD $22.20
- CYRX N/A
- Revenue Growth
- VMD 19.97
- CYRX 11.75
- 52 Week Low
- VMD $6.14
- CYRX $4.58
- 52 Week High
- VMD $9.81
- CYRX $11.64
- Technical
- Relative Strength Index (RSI)
- VMD 46.10
- CYRX 47.07
- Support Level
- VMD $6.36
- CYRX $5.91
- Resistance Level
- VMD $6.84
- CYRX $6.18
- Average True Range (ATR)
- VMD 0.21
- CYRX 0.41
- MACD
- VMD -0.01
- CYRX -0.09
- Stochastic Oscillator
- VMD 52.78
- CYRX 13.22
About VMD Viemed Healthcare Inc.
Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.